---
title: "Kairos Pharma announces interim Phase I data for ENV-105 in NSCLC"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292905923.md"
description: "A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser."
datetime: "2026-07-16T09:46:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292905923.md)
  - [en](https://longbridge.com/en/news/292905923.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292905923.md)
generator: "portal-rs"
---

# Kairos Pharma announces interim Phase I data for ENV-105 in NSCLC

A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.

### Related Stocks

- [KAPA.US](https://longbridge.com/en/quote/KAPA.US.md)

## Related News & Research

- [Netflix parts ways with a key ad exec in a leadership shake-up. Read the leaked memo from its ad chief.](https://longbridge.com/en/news/296834043.md)
- [FDA approves Priovant’s rare autoimmune therapy Lisraya in indication first](https://longbridge.com/en/news/297336275.md)
- [How Is Home Depot’s Stock Performance Compared to Other Consumer Discretionary Stocks](https://longbridge.com/en/news/297407039.md)
- [SK inks $795m Biohaven epilepsy deal, entering potassium channel opener race](https://longbridge.com/en/news/297220838.md)
- ["Oreogate" on Instagram went viral. But was it all a fake ad for an AI company?](https://longbridge.com/en/news/297357874.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**